Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

Detalles Bibliográficos
Autores principales: Bauer, A, Podola, L, Haule, A, Sudi, L, Nilsson, C, Mann, P, Missanga, M, Kaluwa, B, Maboko, L, Lueer, C, Mwakatima, M, Aboud, S, Bakari, M, Currier, J, Robb, M, Joseph, S, McCormack, S, Lyamuya, E, Wahren, B, Sandström, E, Biberfeld, G, Hoelscher, M, Kroidl, A, Geldmacher, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441414/
http://dx.doi.org/10.1186/1742-4690-9-S2-P330
_version_ 1782243283914719232
author Bauer, A
Podola, L
Haule, A
Sudi, L
Nilsson, C
Mann, P
Missanga, M
Kaluwa, B
Maboko, L
Lueer, C
Mwakatima, M
Aboud, S
Bakari, M
Currier, J
Robb, M
Joseph, S
McCormack, S
Lyamuya, E
Wahren, B
Sandström, E
Biberfeld, G
Hoelscher, M
Kroidl, A
Geldmacher, C
author_facet Bauer, A
Podola, L
Haule, A
Sudi, L
Nilsson, C
Mann, P
Missanga, M
Kaluwa, B
Maboko, L
Lueer, C
Mwakatima, M
Aboud, S
Bakari, M
Currier, J
Robb, M
Joseph, S
McCormack, S
Lyamuya, E
Wahren, B
Sandström, E
Biberfeld, G
Hoelscher, M
Kroidl, A
Geldmacher, C
author_sort Bauer, A
collection PubMed
description
format Online
Article
Text
id pubmed-3441414
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34414142012-09-18 Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime Bauer, A Podola, L Haule, A Sudi, L Nilsson, C Mann, P Missanga, M Kaluwa, B Maboko, L Lueer, C Mwakatima, M Aboud, S Bakari, M Currier, J Robb, M Joseph, S McCormack, S Lyamuya, E Wahren, B Sandström, E Biberfeld, G Hoelscher, M Kroidl, A Geldmacher, C Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441414/ http://dx.doi.org/10.1186/1742-4690-9-S2-P330 Text en Copyright ©2012 Bauer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Bauer, A
Podola, L
Haule, A
Sudi, L
Nilsson, C
Mann, P
Missanga, M
Kaluwa, B
Maboko, L
Lueer, C
Mwakatima, M
Aboud, S
Bakari, M
Currier, J
Robb, M
Joseph, S
McCormack, S
Lyamuya, E
Wahren, B
Sandström, E
Biberfeld, G
Hoelscher, M
Kroidl, A
Geldmacher, C
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title_full Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title_fullStr Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title_full_unstemmed Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title_short Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
title_sort preferential targeting of conserved gag regions after vaccination with a heterologous dna prime modified vaccinia ankara boost hiv vaccine regime
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441414/
http://dx.doi.org/10.1186/1742-4690-9-S2-P330
work_keys_str_mv AT bauera preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT podolal preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT haulea preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT sudil preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT nilssonc preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT mannp preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT missangam preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT kaluwab preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT mabokol preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT lueerc preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT mwakatimam preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT abouds preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT bakarim preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT currierj preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT robbm preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT josephs preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT mccormacks preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT lyamuyae preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT wahrenb preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT sandstrome preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT biberfeldg preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT hoelscherm preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT kroidla preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime
AT geldmacherc preferentialtargetingofconservedgagregionsaftervaccinationwithaheterologousdnaprimemodifiedvacciniaankaraboosthivvaccineregime

Ejemplares similares